A phase II trial of marimastat in advanced pancreatic cancer.

A phase II trial of marimastat in advanced pancreatic cancer.

Pancreatic cancer has a poor response to conventional chemotherapy and radiotherapy. Inhibition of matrix metalloproteinase activity involved in tumour invasion and metastases is a novel biological approach for cancer treatment. This multicentre phase II clinical trial assessed marimastat, an oral m...

Full description

Bibliographic Details
Main Authors:	Evans, J, Stark, A, Johnson, C, Daniel, F, Carmichael, J, Buckels, J, Imrie, C, Brown, P, Neoptolemos, J
Format:	Journal article
Language:	English
Published:	2001

Similar Items

Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial.
by: Bramhall, SR, et al.
Published: (2002)

Labeling and enrichment of Arabidopsis thaliana matrix metalloproteases using an active-site directed, marimastat-based photoreactive probe.
by: Lenger, J, et al.
Published: (2012)

Incorporation of Bulky and Cationic Cyclam-Triazole Moieties into Marimastat Can Generate Potent MMP Inhibitory Activity without Inducing Cytotoxicity.
by: Yu, M, et al.
Published: (2013)

Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, <i>Crotalus atrox</i>
by: Harry J. Layfield, et al.
Published: (2020-05-01)

A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.
by: Markham, C, et al.
Published: (2003)

Pulmonary delivery of the broad-spectrum matrix metalloproteinase inhibitor marimastat diminishes multiwalled carbon nanotube-induced circulating bioactivity without reducing pulmonary inflammation
by: Tamara L. Young, et al.
Published: (2021-09-01)

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
by: Wilson, J, et al.
Published: (2016)

Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
by: Neoptolemos John P, et al.
Published: (2008-07-01)

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
by: Hurt, C, et al.
Published: (2017)

Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
by: Tadashi Uwagawa, et al.
Published: (2022-01-01)

Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
by: Tadashi Uwagawa, et al.
Published: (2022-01-01)

Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial
by: Jakob Liermann, et al.
Published: (2022-05-01)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
by: Mukherjee, S, et al.
Published: (2013)

The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
by: Andres Garcia-Sampedro, et al.
Published: (2021-02-01)

A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer
by: Andrew J. Frankart, et al.
Published: (2022-04-01)

Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I<sup>131 </sup>KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma
by: Bosonnet Lorraine, et al.
Published: (2009-02-01)

Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3)
by: Chambers, J, et al.
Published: (2010)

The CHASIT study: sequential chemo-immunotherapy in patients with locally advanced urothelial cancer – a non-randomized phase II clinical trial
by: V. C. Rutten, et al.
Published: (2023-06-01)

Thymostimulin in advanced hepatocellular carcinoma: A phase II trial
by: Behl Susanne, et al.
Published: (2008-03-01)

Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study
by: Jung Hoon Kim, et al.
Published: (2018-06-01)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
by: Mukherjee, S, et al.
Published: (2024)

PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer
by: Julia E. Douglas, et al.
Published: (2022-01-01)

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
by: Katz Frieder, et al.
Published: (2006-12-01)

A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer.
by: Martin, N, et al.
Published: (2004)

A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
by: Devalingam Mahalingam, et al.
Published: (2018-05-01)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
by: Brunner, T, et al.
Published: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
by: Brunner, T, et al.
Published: (2008)

Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trials.
by: Cunningham, D, et al.
Published: (2002)

18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer
by: Ronald L. Korn, et al.
Published: (2017-08-01)

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial
by: Toomey Mary, et al.
Published: (2011-05-01)

Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers
by: Charles A. Kunos, et al.
Published: (2019-10-01)

Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study
by: Alessandro Passardi, et al.
Published: (2019-05-01)

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
by: Zhang Yujian, et al.
Published: (2010-07-01)

Efficacy of Endoscopic Ultrasound-Guided Ablation with the HybridTherm Probe in Locally Advanced or Borderline Resectable Pancreatic Cancer: A Phase II Randomized Controlled Trial
by: Sabrina Gloria Giulia Testoni, et al.
Published: (2021-09-01)

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer erbitux, radiotherapy and UFT (PERU) trial.
by: Khan, K, et al.
Published: (2016)

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
by: Mouhammed Amir Habra, et al.
Published: (2019-09-01)

A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients
by: Janielle K.‐A. Taylor, et al.
Published: (2022-12-01)

Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
by: Esther N. Pijnappel, et al.
Published: (2021-09-01)

Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial
by: Jeremy Tey, et al.
Published: (2019-04-01)

Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.
by: Kirkwood, J, et al.
Published: (2012)